Cystic Fibrosis in the African Diaspora

Area of Science:

• Genetics
• Molecular Biology
• Public Health

Background:

• Accurate diagnosis of cystic fibrosis (CF) is vital for patient health and longevity.
• CF-causing mutations are population-specific, complicating diagnosis in diverse ancestries.
• Most CF mutation research has focused on European populations, leaving gaps in understanding for other groups.

Purpose of the Study:

• To identify causative cystic fibrosis mutations in individuals of African descent in the Americas.
• To assess the current state of molecular diagnosis for CF in this population.
• To highlight the need for comprehensive mutation characterization in diverse populations.

Main Methods:

• A systematic survey of published data on CF mutations in patients of African descent in the Americas.
• Analysis of tested chromosomes and identified CF alleles.
• Review of mutation frequency and geographical distribution.

Main Results:

• Across 6 countries, 1,584 chromosomes were tested, with 55.3% of alleles remaining unidentified.
• 59 CF mutations were identified, with 41 confirmed causative, 17 lacking functional studies, and one with variable effects.
• The most common mutations included ΔF508 (29.4%), 3120+1G>A (8.4%), and G85E (3.8%).
• The majority of identified mutations (81.4%) were reported in only one country.

Conclusions:

• Significant gaps exist in identifying CF-causing mutations in people of African descent in the Americas.
• Current diagnostic approaches may be insufficient due to population-specific mutation profiles.
• Further research is essential to fully characterize the CF mutation spectrum in the diaspora for improved diagnostic accuracy and treatment.